Meyka Pro banner
AtriCure, Inc.

AtriCure, Inc. (ATRC) Stock Overview

Explore AtriCure, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATRC●NASDAQ
HealthcareMedical - Instruments & Supplies
$55.39
$1.28(2.37%)
U.S. Market opens in 51h 34m

AtriCure, Inc. (ATRC)

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E Ratio183.28
EPS (TTM)$0.03
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$60.54
3 Months$75.83
1 Year Target$45.22

ATRC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of AtriCure, Inc. (NASDAQ: ATRC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AtriCure, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ATRC on the NASDAQ shows an RSI of 43.57, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $45.22 for the NASDAQ listing.

Key metrics behind AtriCure, Inc.'s NASDAQ-traded stock include a P/E ratio of 183.28 and a market capitalization of 2.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ATRC on the NASDAQ.

Price Performance (NASDAQ: ATRC)

1-Day Change
2.37%
5-Day Change
-1.28%
1-Month Change
-3.95%
3-Month Change
16.64%
6-Month Change
91.00%
Year-to-Date (YTD) Change
40.02%
1-Year Change
66.59%
3-Year Change
32.07%
5-Year Change
-27.07%
All-Time (Max) Change
293.39%

Contact Information

513 755 4100
7555 Innovation Way, Mason, OH, 45040

Company Facts

13,500 Employees
IPO DateAug 5, 2005
CountryUS
Actively Trading

Frequently Asked Questions